VERTEX PHARMACEUTICALS INCORPORATED
Sign in to add to a watchlist →
lobbying_client · US · canonical: vertex pharmaceuticals · 8 aliases · 8 outbound · 27 inbound
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-18 · lobbied by Kate Kalutkiewicz · lda_lobbyist_client
- 2026-05-18 · lobbied by Matthew O Schumaker · lda_lobbyist_client
- 2026-05-18 · lobbied by Swarna Vallurupalli · lda_lobbyist_client
- 2026-05-18 · lobbied by Joshua David Odintz · lda_lobbyist_client
- 2026-05-18 · lobbied by Kyle Hill · lda_lobbyist_client
- 2026-05-18 · lobbied by Adam Buckalew · lda_lobbyist_client
- 2026-05-18 · lobbied by Adam Buckalew · lda_lobbyist_client
- 2026-05-18 · lobbied by Hazen Clay Marshall · lda_lobbyist_client
- 2026-05-18 · lobbied by Michael Hayes · lda_lobbyist_client
- 2026-05-18 · lobbied by Laura Friedel · lda_lobbyist_client
- 2026-05-18 · lobbied by Veronica Jackson · lda_lobbyist_client
- 2026-05-18 · lobbied by Hannah Beth Cornwell · lda_lobbyist_client
- 2026-05-18 · lobbied by Monica Popp · lda_lobbyist_client
- 2026-05-18 · lobbied by Andrew Joseph Siracuse · lda_lobbyist_client
- 2026-05-18 · lobbied by E. Brandon Garrett · lda_lobbyist_client
- 2026-05-18 · lobbied by Mike Mckay · lda_lobbyist_client
- 2026-01-01 · lobbied for by SALT POINT STRATEGIES $10,000 · lda_filing
- 2026-01-01 · lobbied for by EMPIRE CONSULTING GROUP $50,000 · lda_filing
- 2026-01-01 · lobbied for by ALB SOLUTIONS · lda_filing
- 2026-01-01 · lobbied on Alternatives to PAIN Act (s.475) · lobbying_bill_mention
- 2026-01-01 · lobbied on Alternatives to PAIN Act (h.r. 1227) · lobbying_bill_mention
- 2026-01-01 · lobbied for by MARSHALL & POPP, LLC $60,000 · lda_filing
- 2026-01-01 · lobbied on New Era of Preventing End-Stage Kidney Disease Act (h.r. 1518) · lobbying_bill_mention
- 2026-01-01 · lobbied on HELP Copays Act (h.r. 6423) · lobbying_bill_mention
- 2026-01-01 · lobbied for by ALB SOLUTIONS $50,000 · lda_filing
- 2026-01-01 · lobbied for by ALSTON & BIRD LLP · lda_filing
- 2026-01-01 · lobbied on Alternatives to PAIN Act (h.r. 1227) · lobbying_bill_mention
- 2026-01-01 · lobbied for by VERTEX PHARMACEUTICALS INCORPORATED $1,140,000 · lda_filing
- 2026-01-01 · lobbied for by HOLLAND & KNIGHT LLP $20,000 · lda_filing
- 2026-01-01 · lobbied on Alternatives to PAIN Act (hr 1227) · lobbying_bill_mention
- 2026-01-01 · lobbied on Cameron’s Law (h.r. 1414) · lobbying_bill_mention
- 2026-01-01 · lobbied on Alternatives to PAIN Act (s. 475) · lobbying_bill_mention
- 2025-01-01 · lobbied for by MCLARTY INBOUND LLC · lda_filing
- 2025-01-01 · lobbied for by MARSHALL & POPP, LLC · lda_filing
- 2025-01-01 · lobbied for by SALT POINT STRATEGIES · lda_filing
Lobbying disclosures — as CLIENT (11)
Filings where this org hired a lobbying firm. Income + expenses come from the LDA disclosure.
| Posted | Filing | Year | Period | Registrant (lobbying firm) | Income | Expenses |
|---|---|---|---|---|---|---|
| 2026-04-18 | 1st Quarter - Report | 2026 | first_quarter | 400703105 | $50,000 | — |
| 2026-04-17 | 1st Quarter - Report | 2026 | first_quarter | 40027242 | — | $1,140,000 |
| 2026-04-17 | 1st Quarter - Report | 2026 | first_quarter | 401105121 | $60,000 | — |
| 2026-04-17 | 1st Quarter - Termination | 2026 | first_quarter | 401105514 | $10,000 | — |
| 2026-04-15 | 1st Quarter - Report | 2026 | first_quarter | 401105973 | $50,000 | — |
| 2026-04-10 | 1st Quarter - Report | 2026 | first_quarter | 18466 | $20,000 | — |
| 2026-03-20 | Registration | 2026 | first_quarter | 1182 | — | — |
| 2026-03-10 | Registration | 2026 | first_quarter | 401105973 | — | — |
| 2025-04-03 | Registration | 2025 | first_quarter | 401103585 | — | — |
| 2025-03-24 | Registration | 2025 | first_quarter | 401105121 | — | — |
| 2025-02-24 | Registration | 2025 | first_quarter | 401105514 | — | — |
Aliases (8)
| source | id | name at source | jurisdiction | confidence | linked by | linked at |
|---|---|---|---|---|---|---|
| lda_client | 71893 | VERTEX PHARMACEUTICALS INCORPORATED | US | gold | backfill_0029 | |
| lda_client | 188223 | VERTEX PHARMACEUTICALS INCORPORATED | US | gold | backfill_0029 | |
| lda_client | 63465 | VERTEX PHARMACEUTICALS INCORPORATED | US | gold | backfill_0029 | |
| lda_client | 65129 | VERTEX PHARMACEUTICALS INCORPORATED | US | gold | backfill_0029 | |
| lda_client | 64435 | VERTEX PHARMACEUTICALS | US | gold | backfill_0029 | |
| lda_client | 65435 | VERTEX PHARMACEUTICALS INCORPORATED | US | gold | backfill_0029 | |
| lda_client | 71687 | VERTEX PHARMACEUTICALS | US | gold | backfill_0029 | |
| lda_client | 212057 | VERTEX PHARMACEUTICALS INCORPORATED | US | gold | backfill_0029 |
Outbound edges (8)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | lobbies_on_bill | HR 1227 — Alternatives to PAIN Act | — | H.R. 1227 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 1414 — Cameron’s Law | — | H.R. 1414 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 1518 — New Era of Preventing End-Stage Kidney Disease Act | — | H.R. 1518 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 6423 — HELP Copays Act | — | H.R. 6423 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 475 — Alternatives to PAIN Act | — | S. 475 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 1227 — Alternatives to PAIN Act | — | H.R. 1227 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 475 — Alternatives to PAIN Act | — | S.475 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 1227 — Alternatives to PAIN Act | — | HR 1227 | lobbying_bill_mention |
Inbound edges (27)
| date | from | type | amount | source |
|---|---|---|---|---|
| — | Mike Mckay | lobbied_for | — | lda_lobbyist_client |
| — | E. Brandon Garrett | lobbied_for | — | lda_lobbyist_client |
| — | Andrew Joseph Siracuse | lobbied_for | — | lda_lobbyist_client |
| — | Monica Popp | lobbied_for | — | lda_lobbyist_client |
| — | Hannah Beth Cornwell | lobbied_for | — | lda_lobbyist_client |
| — | Veronica Jackson | lobbied_for | — | lda_lobbyist_client |
| — | Laura Friedel | lobbied_for | — | lda_lobbyist_client |
| — | Michael Hayes | lobbied_for | — | lda_lobbyist_client |
| — | Hazen Clay Marshall | lobbied_for | — | lda_lobbyist_client |
| — | Adam Buckalew | lobbied_for | — | lda_lobbyist_client |
| — | Adam Buckalew | lobbied_for | — | lda_lobbyist_client |
| — | Kyle Hill | lobbied_for | — | lda_lobbyist_client |
| — | Swarna Vallurupalli | lobbied_for | — | lda_lobbyist_client |
| — | Joshua David Odintz | lobbied_for | — | lda_lobbyist_client |
| — | Matthew O Schumaker | lobbied_for | — | lda_lobbyist_client |
| — | Kate Kalutkiewicz | lobbied_for | — | lda_lobbyist_client |
| 2026-01-01 | ALSTON & BIRD LLP | lobbies_for | — | lda_filing |
| 2026-01-01 | ALB SOLUTIONS | lobbies_for | — | lda_filing |
| 2025-01-01 | SALT POINT STRATEGIES | lobbies_for | — | lda_filing |
| 2025-01-01 | MARSHALL & POPP, LLC | lobbies_for | — | lda_filing |
| 2025-01-01 | MCLARTY INBOUND LLC | lobbies_for | — | lda_filing |
| 2026-01-01 | VERTEX PHARMACEUTICALS INCORPORATED | lobbies_for | $1,140,000 | lda_filing |
| 2026-01-01 | MARSHALL & POPP, LLC | lobbies_for | $60,000 | lda_filing |
| 2026-01-01 | EMPIRE CONSULTING GROUP | lobbies_for | $50,000 | lda_filing |
| 2026-01-01 | ALB SOLUTIONS | lobbies_for | $50,000 | lda_filing |
| 2026-01-01 | HOLLAND & KNIGHT LLP | lobbies_for | $20,000 | lda_filing |
| 2026-01-01 | SALT POINT STRATEGIES | lobbies_for | $10,000 | lda_filing |